Hypoxia-mimetic agents desferrioxamine and cobalt chloride induce leukemic cell apoptosis through different hypoxia-inducible factor-1α independent mechanisms

被引:92
作者
Guo, M
Song, LP
Jiang, Y
Liu, W
Chen, GQ
机构
[1] Shanghai Inst Biol Sci, Hlth Sci Ctr, Shanghai 200025, Peoples R China
[2] Chinese Acad Sci, Shanghai Jiao Tong Univ, Sch Med, Grad Sch, Shanghai 200025, Peoples R China
[3] Shanghai Med Univ 2, Shanghai, Peoples R China
[4] SJU SM, Key Lab Cell Differentiat & Apoptosis, Dept Pathophysiol, Shanghai 200025, Peoples R China
基金
中国国家自然科学基金;
关键词
apoptosis; cobalt chloride; desferrioxamine; HIF-1; alpha; leukemia;
D O I
10.1007/s10495-005-3085-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hypoxia presents pro-apoptotic and anti-apoptotic biphasic effects that appear to be dependent upon cell types and conditions around cells. The substantial reports demonstrated that commonly used hypoxia-mimetic agents cobalt chloride (CoCl2) and desferrioxamine (DFO) could also induce apoptosis in many different kinds of cells, but the mechanism was poorly understood. In this work, we compare the apoptosis-inducing effects of these two hypoxia-mimetic agents with acute myeloid leukemic cell lines NB4 and U937 as in vitro models. The results show that both of them induce these leukemic cells to undergo apoptosis with a loss of mitochondrial transmembrane potentials (Delta Psi m), the activation of caspase-3/8 and the cleavage of anti-apoptotic protein Mcl-1, together with the accumulation of hypoxia-inducible factor-1 alpha (HIF-1 alpha) protein, a critical regulator for the cellular response to hypoxia. Metavanadate and sodium nitroprusside significantly abrogate DFO rather than CoCl2-induced mitochondrial Delta Psi m collapse, caspase-3/8 activation, Mcl-1 cleavage and apoptosis, but they fail to influence DFO and CoCl2-induced HIF-1 alpha protein accumulation. Moreover, inducible expression of HIF-1 alpha gene dose not alter DFO and CoCl2-induced apoptosis in U937 cells. In conclusion, these results propose that although both DFO and CoCl2-induced leukemic cell apoptosis by mitochondrial pathway-dependent and HIF-1 alpha-independent mechanisms, DFO and CoCl2-induced apoptosis involves different initiating signal pathways that remain to be investigated.
引用
收藏
页码:67 / 77
页数:11
相关论文
共 51 条
[1]   Stabilization of wild-type p53 by hypoxia-inducible factor 1α [J].
An, WG ;
Kanekal, M ;
Simon, MC ;
Maltepe, E ;
Blagosklonny, MV ;
Neckers, LM .
NATURE, 1998, 392 (6674) :405-408
[2]   Inhibition of proteasome activity is involved in cobalt-induced apoptosis of human alveolar macrophages [J].
Araya, J ;
Maruyama, M ;
Inoue, A ;
Fujita, T ;
Kawahara, J ;
Sassa, K ;
Hayashi, R ;
Kawagishi, Y ;
Yamashita, N ;
Sugiyama, E ;
Kobayashi, M .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2002, 283 (04) :L849-L858
[3]  
BECTON DL, 1989, CANCER RES, V49, P4809
[4]   Overexpression of the nucleoporin CAN/NUP214 induces growth arrest, nucleocytoplasmic transport defects, and apoptosis [J].
Boer, J ;
Bonten-Surtel, J ;
Grosveld, G .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (03) :1236-1247
[5]   Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1α [J].
Chan, DA ;
Sutphin, PD ;
Denko, NC ;
Giaccia, AJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (42) :40112-40117
[6]  
Chen GQ, 1996, BLOOD, V88, P1052
[7]   A new role for hypoxia in tumor progression: Induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs [J].
Coquelle, A ;
Toledo, F ;
Stern, S ;
Bieth, A ;
Debatisse, M .
MOLECULAR CELL, 1998, 2 (02) :259-265
[8]   Apoptosis pathways in cancer and cancer therapy [J].
Debatin, KM .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2004, 53 (03) :153-159
[9]   Hypoxia selection of death-resistant cells -: A role for Bcl-XL [J].
Dong, Z ;
Wang, JZ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (10) :9215-9221
[10]   Apoptosis-resistance of hypoxic cells - Multiple factors involved and a role for IAP-2 [J].
Dong, Z ;
Wang, JZ ;
Yu, FS ;
Venkatachalam, MA .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (02) :663-671